VivaGel® BV Launch(es), page-103

Well I personally cannot complain .... Another detailed response from SPL Investor Relations at 1.52pm ? .... someone has put a rocket under them ???

This email I sent was only sent two days ago and was in relation to Aspen Website and how there was no mention of Starpharma or their 2016 agreement etc etc

Dear Col

Thank you for your email.

We appreciate your interest in the launch and promotion of VivaGel® BV in Australia, which is currently being marketed by our partner Aspen under the brand name Fleurstat BVgel.

We note that Aspen posts very few news stories to its Australian corporate website and the last news item posted was in 2017. We also note that the Aspen Australia corporate website is not aimed at parties relevant to Fleurstat - BV patients, doctors or pharmacists. Aspen’s communication and promotion to these groups is done directly via dedicated salesforce personnel and specialised promotional materials which have been developed for Fleurstat.

Aspen is currently undertaking multiple promotional activities, which include sales conferences, pharmacist training and other key marketing initiatives leading up to the formal launch of Fleurstat BVgel. Aspen representatives have already undertaken specific product training and are currently calling on pharmacists and GPs in preparation for product launch.

Starpharma has been involved in the development of Aspen’s advertising materials and whilst they are currently embargoed from public release we hope to be able to share some of these with shareholders at a later date. These materials will be targeted to consumers, pharmacies and GPs, but even at that time we wouldn’t expect them to be posted on their Australian corporate website, but via more specific targeted platforms.

Thank you and kind regards

Investor Relations
Starpharma Holdings Limited
4-6 Southampton Crescent
Abbotsford 3067 VIC

Postal Address:
PO Box 2022
Preston Victoria 3072 Australia